Elevate Capital is an inclusive venture capital firm that provides funding and mentorship to underrepresented entrepreneurs, including women, minorities, and veterans. The firm focuses on early-stage startups and aims to create a more diverse and equitable entrepreneurial ecosystem.

Elevate Capital

浙商创投股份有限公司 is involved in investment activities, particularly in ventures related to technology and healthcare startups, as evidenced by its investment in 太美医疗科技 and other listed enterprises.

浙商创投股份有限公司

Medical Devices Venture is a holding company that develops a portfolio of investments in Med Tech start-ups. The aim is to combine the expertise of researchers in hospital and university settings with industrialization and commercialization capabilities.

Medical Devices Venture

For some populations, there is a noticeable gap in gaining access to investment capital. These aspiring entrepreneurs are both underserved and overlooked, yet they have the courage and vision it takes to start and scale a business. At Elevate Capital, we believe there is a tremendous opportunity to invest early and offer mentorship to these entrepreneurs. We provide the venture capital and guidance they need to turn their startups into great companies.

We support visionaries from all walks of life and help them reach entrepreneurial success. 

Metric
Company Name	Elevate Capital	浙商创投股份有限公司	Medical Devices Venture
Symbol
MSH ID	VC:ELEVATE	CN:COM:ZSVC	COM:MEDICALDEVICESVENTURE
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Financial Services & Finance	Financial Services & Finance	Healthcare & Health Services
Industry	Venture Capital	Venture Capital	Medical Devices
Country	US	CN	FR
Stage
Employee Count	20
Website	elevate.vc	zsvc.com.cn	medicaldevicesventure.com
LinkedIn	elevate-capital-fund	%E6%B5%99%E5%95%86%E5%88%9B%E6%8A%95%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8	medical-devices-venture
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic		78
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score	10.36
28-Day Growth Score	16.39
90-Day Growth Score	14.09
365-Day Growth Score	13.03

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

VC:ELEVATE

Elevate Capital

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue